Pharmaceutical Business review

US Oncology launches new cancer services division

Innovent Oncology offers payers and oncologists solutions that combine evidence-based treatment guidelines, patient support services and advance care planning to improve clinical outcomes while addressing costs, the company said.

The core services offered include – Level I Pathways: Physician-developed, evidence-based pathways that reduce treatment variability and resulting costs while providing a platform for standardization, outcomes measurement and ongoing peer review.

Patient Support Services: An oncology-specific disease management program that increases treatment compliance, helps patients monitor and manage side effects, and reduces unnecessary ER visits and hospitalizations.

Advance Care Planning: Transition care planning and implementation that prepares patients early in their care process for potential end-of-life issues by addressing clinical, social, financial and spiritual needs.

According to the company, Innovent Oncology offers an integrated solution that is a comprehensive program addressing the primary cancer care cost drivers including – the wide variation in treatment selection, side effects that prompt ER visits and hospitalizations, and ineffective interventions near the end of life.